Advisory: Give yourself extra time when travelling by car to Toronto General Hospital, Princess Margaret Cancer Centre, or Toronto Rehab University Centre. City of Toronto construction on University Ave. may cause delays.
At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
Toronto (Aug. 30, 2018) – The role of insulin as a boost to the immune system to improve its ability to fight infection has been detailed for the first time by Toronto General Hospital Research Institute (TGHRI) scientists.
TGHRI scientists have identified a specific insulin signaling pathway that, when activated, revs up the response of T cells in the immune system to divide rapidly and secrete cytokines, chemical messenger proteins that activate the rest of the immune system. A fast and effective immune response protects us against disease and life-threatening infections by destroying infected cells or microbes, while a wrong or inefficient one can cause immune system disorders or diseases to develop.
The research findings are published in a paper called, "Insulin receptor mediated stimulation boosts T cell immunity during inflammation and infection," in
Cell Metabolism, August 30, 2018, by first author Dr. Sue Tsai, postdoctoral fellow, and senior authors, Dr. Daniel Winer, Anatomical Pathologist, University Health Network and Scientist, Toronto General Hospital Research Institute and Dr. Shawn Winer, Anatomical Pathologist, St. Michael's Hospital.
"We have identified one of metabolism's most popular hormones, specifically the insulin signaling pathway, as a novel 'co-stimulatory' driver of immune system function," says Dr. Daniel Winer, who is also Assistant Professor, Department of Laboratory Medicine and Pathobiology at University of Toronto. "Our work characterizes the role of this signaling pathway in immune cells, mainly T cells, opening up avenues in the future to better regulate the immune system."
Although much work has been done in past years on the role of insulin in organs such as the liver, muscle and in fat to understand regulation of glucose or blood sugar and how the body metabolizes or turns it into energy, little is known about how insulin impacts the immune system.
"The link between insulin and the immune system is not obvious," says Dr. Tsai, "it is fascinating to learn that immune cells, which require energy and nutrients for proper functioning just like all other cells in the body, are also regulated by metabolic signals from insulin."
The suggestion to test this link came to the research team as a result of the observation that people with type 2 diabetes or who are obese, and at higher risk for developing type 2 diabetes, do not respond well or are resistant to insulin. In their previous work, the Winer labs demonstrated that immune cells inside abdominal fat cause the release of 'pro-inflammatory' chemicals, which make the body less sensitive to insulin.
Interestingly, notes Dr. Tsai, obesity is linked to whole body insulin resistance, and obese insulin-resistant individuals and mice are known to have weakened immune responses, and increased susceptibility to developing severe infections.
It may be, she reasons, that there is a link between persistent and chronic inflammation, immune dysfunction and insulin resistance, with the end result that T cells stop responding and become functionally impaired.
The goal of this research was to study how insulin regulates T cell function and what causes T cells to stop responding to insulin, Dr. Tsai says, adding that T cells were chosen because they play a pivotal role in self-defence against infections.
Using genetically engineered mice, the research team designed mice with T cells that did not have an insulin receptor on them, mimicking insulin resistance. They then observed what happened to the T cells in the mice under different stressors, such as the H1N1 flu virus.
T cells need more signals to boost their activation after they encounter a foreign invader, explains Dr. Winer, adding that, "the insulin receptor or signaling molecule is like a second push to the immune system to ensure that it can fight off the infection with the best possible weapons it has."
Without the added boost or kickstart provided by the insulin receptor to help "re-energize" the T cells to mount an effective immune response, the T cells failed to destroy viruses such as the H1N1 influenza.
"T cells are at the heart of so many diseases," says Dr. Tsai, "If we can understand them at the cellular level, this will give us the best opportunity to find new pathways to target for new therapies."
In the future, she says, we could harness this insulin signaling pathway to either boost the immune response to create vaccines, for example, or dampen it to heal inflammatory illnesses such as arthritis, ulcerative colitis and Crohn's disease.
Other researchers involved in the study include co-first author Dr. Xavier Clemente-Casares, who is a postdoctoral fellow at the University Health Network in Dr. Daniel Winer's lab, and collaborators Drs. Angela Zhou, Helena Lei, Jennifer Ahn, Yi Tao Chan, Okmi Choi, Helen Luck, Minna Woo, Shannon Dunn, Edgar Engleman and Tania Watts.
The work was funded by the Canadian Institute of Health Research, Diabetes Canada, the J.P. Bickell Foundation Grant, the Banting and Best Diabetes Centre at the University of Toronto, and the Toronto General & Western Hospital Foundation.
Toronto General Hospital is a partner in University Health Network, along with Toronto Western, the Princess Margaret Cancer Centre, the Toronto Rehabilitation Institute and the Michener Institute for Education. The scope of research and complexity of cases at Toronto General Hospital have made it a national and international source for discovery, education and patient care. It has one of the largest hospital-based research programs in Canada, with major research in cardiology, transplantation, diabetes, regenerative medicine, infectious diseases, genomic medicine, psychosocial care and health systems. Toronto General Hospital is a research and teaching hospital affiliated with the University of Toronto.
Phone: 416 340 4636